|Articles|June 1, 2002
ISTA acquires rights to 3 ophthalmic compounds
Irvine, CA-ISTA Pharmaceuticals, Irvine, CA, entered into an agreement with AcSentient Inc. under which ISTA will acquire rights to three late-stage ophthalmology compounds.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope Therapeutics releases positive long-term safety results from EXTEND study
2
Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial
3
Avisi Technologies releases positive 12-month data from VITA Trial
4
4DMT and Otsuka Pharmaceutical partner on 4D-150 in the greater Asia-Pacific region
5














































.png)


